A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from the School of Medicine and the German Center for Neurodegenerative Diseases.
A new study from the School of Medicine has found that decreased deep sleep is associated with early signs of Alzheimer’s disease.
A new study at the School of Medicine finds disparities between African-Americans and Caucasians in a key biomarker for Alzheimer’s disease — suggesting that tools to diagnose the disease in Caucasian populations may not work as well in African-Americans.
The Source looks back at some of our most read and most shared stories of 2018. Highlights include good news (a new chancellor), bad news (even light drinking increases risk of death) and who knew news (“collective narcissism” is real and Virginians have it).
A team of researchers at Washington University School of Medicine in St. Louis has been funded by the Chan Zuckerberg Initiative to study the root causes of neurodegenerative disorders.
In the largest genetic study of Alzheimer’s disease, researchers at the School of Medicine and the University of California, San Francisco, have found that genes that increase risk of cardiovascular disease also heighten the risk for Alzheimer’s.
Using technology similar to what is found in many eye doctors’ offices, School of Medicine researchers have detected evidence suggesting Alzheimer’s in older patients who had no symptoms of the disease.
School of Medicine researchers have found that the pathways through which various types of brain cells are damaged by Alzheimer’s disease varies, depending on the genes involved. The findings are published in the journal Genome Medicine.
Sticky amyloid plaques play a role in Alzheimer’s disease. School of Medicine researchers have shown that an antibody targeting a minor part of the plaques – a protein known as APOE – can sweep away the damaging plaques, opening potential treatment options.
Researchers at the School of Medicine are getting a clearer picture of the connection between tau and amyloid beta, the two proteins at the heart of Alzheimer’s disease. Their insights may lead to new treatments.